Sign In
Buy GSK
$51.53
+0.0200 (+0.0388%)
At Close: Aug 04, 2026
What Could a Recession Mean for Healthcare Stocks?
03:30pm, Thursday, 09'th Jun 2022 The Motley Fool
It depends on which subsector you're talking about.
GlaxoSmithKline (GSK) Stock Moves -0.11%: What You Should Know
10:00pm, Wednesday, 08'th Jun 2022 Zacks Investment Research
GlaxoSmithKline (GSK) closed the most recent trading day at $44.20, moving -0.11% from the previous trading session.
Diamond Hill International Fund 2022 Market Commentary
04:03am, Wednesday, 08'th Jun 2022 Seeking Alpha
During Q1 '22, the Diamond Hill International Fund held up better than the Morningstar Global Markets ex-US Index. Click here to read the full fund letter.
GSK Gets FDA Nod for Measles, Mumps & Rubella Vaccine, Priorix
02:13pm, Monday, 06'th Jun 2022 Zacks Investment Research
The FDA approves GSK's Priorix vaccine for active immunization for the prevention of measles, mumps and rubella in individuals aged 12 months and older.
GlaxoSmithKline (GSK) Gains But Lags Market: What You Should Know
10:00pm, Thursday, 02'nd Jun 2022 Zacks Investment Research
In the latest trading session, GlaxoSmithKline (GSK) closed at $43.39, marking a +0.81% move from the previous day.
GSK Receives Regulatory Nod for Consumer Healthcare Demerger
01:17pm, Thursday, 02'nd Jun 2022 Zacks Investment Research
GSK progresses with the separation of its Consumer Healthcare business from biopharmaceuticals into a separate public company, Haleon, as it gets regulatory approval from the FCA.
Things Are About to Get a Lot More Interesting at Unilever
03:23pm, Wednesday, 01'st Jun 2022 The Motley Fool
A top activist investor sets his sights on shaking things up at the consumer packaged goods giant.
GSK to Boost Vaccine Portfolio With Affinivax Acquisition
03:26pm, Tuesday, 31'st May 2022 Zacks Investment Research
GSK signs an agreement to acquire Affinivax, Inc. for a $2.1 billion upfront payment. The company is looking to boost its vaccine pipeline with this acquisition.
Is Nuveen ESG International Developed Markets Equity ETF (NUDM) a Strong ETF Right Now?
01:59pm, Tuesday, 31'st May 2022 Zacks Investment Research
Smart Beta ETF report for NUDM
GSK to pay up to $3.3 billion for biopharma Affinivax
08:50am, Tuesday, 31'st May 2022 MarketWatch
GSK PLC said Tuesday that it has agreed to buy clinical-stage biopharmaceutical company Affinivax, Inc. for up to $3.3 billion.
Wide-Moat Stocks On Sale - The June 2022 Heat Map
07:20am, Tuesday, 31'st May 2022 Seeking Alpha
Our 3-step process focuses on wide-moat stocks (as per Morningstar’s rating). We are only interested in those targets that are attractively valued in historical comparison.
Biotech stocks get a boost, or plunge, as new clinical data is shared before major cancer meeting
12:54pm, Sunday, 29'th May 2022 MarketWatch
This includes Arcellx, Iovance Biotherapeutics, and ZymeWorks.
Entasis (ETTX) Stock Rises on Buyout Offer From Innoviva
07:03pm, Tuesday, 24'th May 2022 Zacks Investment Research
Innoviva (INVA) is set to acquire Entasis (ETTX) for $2.20 per share in cash. The transaction is likely to close by third-quarter 2022.
Zacks Industry Outlook Highlights Eli Lilly, Novo Nordisk, Merck, and Glaxo
01:25pm, Friday, 20'th May 2022 Zacks Investment Research
Eli Lilly, Novo Nordisk, Merck, and Glaxo are part of Zacks Industry Outlook article.
Top Analyst Reports for Apple, Berkshire Hathaway, & S&P Global
09:08pm, Thursday, 19'th May 2022 Zacks Investment Research
Today's Research Daily features new research reports on 16 major stocks, including Apple Inc. (AAPL), Berkshire Hathaway Inc. (BRK.B), and S&P Global Inc. (SPGI).
